| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals Incorporated | $451.63 | -1.6% | $114.88B | 29.5 | 530.1% | — | Healthcare | 0.7% | 10.4% | ||
| 2 | Ascendis Pharma A/S | $230.83 | -0.1% | $14.26B | -55.7 | 229.7% | — | Healthcare | 35.2% | 135.3% | ||
| 3 | BridgeBio Pharma, Inc. | $66.27 | -1.7% | $12.98B | -17.5 | -6.2% | — | Healthcare | 65.7% | 355.2% | ||
| 4 | BioMarin Pharmaceutical Inc. | $54.69 | -0.6% | $10.52B | 30.4 | -48.3% | — | Healthcare | -1% | 9.9% | ||
| 5 | Corcept Therapeutics Incorporated | $79.91 | -2.3% | $8.58B | 97.5 | -69.8% | — | Healthcare | 12.2% | 12.2% | ||
| 6 | PTC Therapeutics, Inc. | $78.98 | 0.6% | $6.55B | 10.2 | -135.9% | — | Healthcare | 56.6% | -53.3% | ||
| 7 | Cogent Biosciences, Inc. | $34.54 | 2.6% | $5.9B | -13.5 | -30.5% | — | Healthcare | 377.1% | — | ||
| 8 | Mirum Pharmaceuticals, Inc. | $107.13 | 5% | $5.38B | -227.9 | -745.9% | — | Healthcare | 110.9% | 8% | ||
| 9 | Travere Therapeutics, Inc. | $55.15 | 1.9% | $5.13B | -98.5 | 81.1% | — | Healthcare | 282.7% | 96% | ||
| 10 | Amicus Therapeutics, Inc. | $14.49 | 0% | $4.55B | -164.8 | 50.9% | — | Healthcare | 152.9% | 20% | ||
| 11 | Edgewise Therapeutics, Inc. | $36.81 | 5.7% | $3.96B | -22.6 | -7.1% | — | Healthcare | 154.4% | — | ||
| 12 | Catalyst Pharmaceuticals, Inc. | $31.38 | -0.1% | $3.84B | 18.7 | 10.2% | — | Healthcare | 37.6% | 11.7% | ||
| 13 | Crinetics Pharmaceuticals, Inc. | $35.87 | 0.3% | $3.78B | -7.2 | -34.6% | — | Healthcare | 17.6% | 2277.5% | ||
| 14 | Soleno Therapeutics, Inc. | $53.01 | 0% | $2.76B | 135.9 | 138.2% | — | Healthcare | -33.2% | — | ||
| 15 | Disc Medicine, Inc. | $70.79 | 0.8% | $2.7B | -11.8 | -69.4% | — | Healthcare | 41.3% | — | ||
| 16 | Ultragenyx Pharmaceutical Inc. | $27.44 | 2% | $2.7B | -4.7 | -3.9% | — | Healthcare | -26.5% | 13.3% | ||
| 17 | Pharvaris N.V. | $32.80 | -1.8% | $2.15B | -9.6 | -0.7% | — | Healthcare | 97.1% | — | ||
| 18 | Agios Pharmaceuticals, Inc. | $34.16 | 3.3% | $2.03B | -4.8 | -164.2% | — | Healthcare | -3.8% | 78.3% | ||
| 19 | Harmony Biosciences Holdings, Inc. | $33.28 | -1.5% | $1.93B | 12.3 | -5.3% | — | Healthcare | 2.5% | 20.7% | ||
| 20 | BioCryst Pharmaceuticals, Inc. | $8.99 | 0.4% | $1.89B | 7.4 | -585.1% | — | Healthcare | -9.7% | 75.9% | ||
| 21 | Sionna Therapeutics, Inc. | $37.30 | 1.6% | $1.68B | -19.8 | -22% | — | Healthcare | 153.2% | — | ||
| 22 | Palvella Therapeutics, Inc. | $113.10 | 0.4% | $1.34B | -30.5 | 58% | — | Healthcare | 451.4% | — | ||
| 23 | Xeris Biopharma Holdings, Inc. | $6.95 | 0.7% | $1.2B | 2171.9 | 121.3% | — | Healthcare | 51.7% | 41.5% | ||
| 24 | Savara Inc. | $5.50 | 2.2% | $1.13B | -10.4 | -14.3% | — | Healthcare | 165.7% | — | ||
| 25 | Pharming Group N.V. | $12.87 | 1.8% | $903M | 321.8 | 186.5% | — | Healthcare | 18.7% | 33196.3% | ||
| 26 | Eton Pharmaceuticals, Inc. | $32.48 | -0.9% | $890M | -191.1 | 65.4% | — | Healthcare | 137.1% | 79.9% | ||
| 27 | Zevra Therapeutics, Inc. | $12.90 | 2.3% | $763M | 9.6 | 213.3% | — | Healthcare | 42.2% | 201.3% | ||
| 28 | Astria Therapeutics, Inc. | $12.58 | 0% | $718M | -7.5 | -2.4% | — | Healthcare | 113.6% | — | ||
| 29 | X4 Pharmaceuticals, Inc. | $4.22 | 4.2% | $533M | -2.3 | -313.1% | — | Healthcare | 49.6% | -71.3% | ||
| 30 | Keros Therapeutics, Inc. | $10.65 | 2.3% | $341M | 4.6 | -712.5% | — | Healthcare | -21.4% | -84.5% | ||
| 31 | Larimar Therapeutics, Inc. | $3.64 | 2.8% | $312M | -1.6 | -40.9% | — | Healthcare | 32.8% | — | ||
| 32 | Fulcrum Therapeutics, Inc. | $3.70 | 5.7% | $200M | -3.1 | -1542.9% | — | Healthcare | -41.8% | -100% | ||
| 33 | Protalix BioTherapeutics, Inc. | $2.22 | 9.9% | $179M | -26.4 | 334.9% | — | Healthcare | 58.6% | 27.8% | ||
| 34 | Rallybio Corporation | $15.97 | 0.3% | $85M | -10.0 | 82.9% | — | Healthcare | 511.9% | 1.2% | ||
| 35 | Spruce Biosciences, Inc. | $52.36 | 7.4% | $72M | -1.0 | 62.6% | — | Healthcare | 869.6% | -100% | ||
| 36 | Mereo BioPharma Group plc | $0.31 | -0.2% | $49M | -1.2 | 99.9% | — | Healthcare | -89.2% | — | ||
| 37 | Grace Therapeutics, Inc. | $2.38 | 7.2% | $37M | -5.1 | 46.4% | — | Healthcare | -22.5% | — | ||
| 38 | Applied Therapeutics, Inc. | $0.10 | 0% | $15M | -0.1 | 93.6% | — | Healthcare | -70.6% | 573.9% | ||
| 39 | Quoin Pharmaceuticals, Ltd. | $4.65 | 0.6% | $9M | -0.4 | 48.4% | — | Healthcare | -44.6% | — | ||
| 40 | Cadrenal Therapeutics, Inc. Common Stock | $3.50 | 12.9% | $9M | -0.5 | 39.2% | — | Healthcare | -73.9% | — | ||